KABI PHARMACIA AKTIEBOLAG
Patent Owner
Stats
- 10 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Mar 27, 2001 most recent publication
Details
- 10 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,394 Total Citation Count
- Mar 25, 1981 Earliest Filing
- 25 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
6207178 Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereofExpiredDec 03, 98Mar 27, 01[A01N]
6034059 Treatment of catabolic states using authentic IGF-1 and hypocaloric amount of nutrientsExpiredMar 17, 93Mar 07, 00[A61K]
5691350 Use of linomide for treatment of retrovirus infections specifically HIV infectionsExpiredJun 05, 95Nov 25, 97[A61K]
5618817 Use of diphenylbutyl-piperazinecarboxamides in the treatment of substance disordersExpiredApr 25, 95Apr 08, 97[A61K]
5411732 Preparation of fused proteins, antibodies and processes thereforeExpiredOct 01, 93May 02, 95[A61K, C12N]
5182081 Product to be used in occlusive epicutaneous testing for the purpose of demonstrating contact allergy to formaldehydeExpiredFeb 01, 90Jan 26, 93[G01N, A61B]
5114971 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertensionExpiredOct 23, 90May 19, 92[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.